Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. [electronic resource] by
- Wei, Andrew H
- Montesinos, Pau
- Ivanov, Vladimir
- DiNardo, Courtney D
- Novak, Jan
- Laribi, Kamel
- Kim, Inho
- Stevens, Don A
- Fiedler, Walter
- Pagoni, Maria
- Samoilova, Olga
- Hu, Yu
- Anagnostopoulos, Achilles
- Bergeron, Julie
- Hou, Jing-Zhou
- Murthy, Vidhya
- Yamauchi, Takahiro
- McDonald, Andrew
- Chyla, Brenda
- Gopalakrishnan, Sathej
- Jiang, Qi
- Mendes, Wellington
- Hayslip, John
- Panayiotidis, Panayiotis
Producer: 20210208
In:
Blood vol. 135
Availability: No items available.
|